Smith Group Asset Management, LLC Zoetis Inc. Transaction History

Smith Group Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$151.44 - $200.09 $3.38 Million - $4.46 Million	-22,290 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$181.39 - $234.03 $14.7 Million - $19 Million	-81,127 Reduced 78.45%	22,290 $4.2 Million
Q4 2021 Feb 02, 2022	BUY	$193.69 - $247.03 $6.29 Million - $8.03 Million	32,500 Added 45.83%	103,417 $21.7 Million
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $13.4 Million - $14.9 Million	70,917 New	70,917 $13.8 Million

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Smith Group Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Smith Group Asset Management, LLC with notifications on news.